90% of diabetics are insured. If we stop selling to insurance and try to sell directly to these patients we would end up being more expensive than competitors and lose those customers. I mean you could argue that if they are paying their own insurence they could cancel and perhaps have a net saving on the insulin, but that seem very risky considering potential comorbidities of diabetes, and you’d lose all other coverage.